
CAS Number64838-55-7
SynonymsEINECS 265-250-7; MFCD00792449; (S)-3-Acetylthio-2-methylpropionyl-L-proline; 1-[(2S)-3-(Acetylsulfanyl)-2-methylpropanoyl]-L-proline; (2S)-1-(3-Acetylthio-2-methyl-1-oxopropyl)-L-proline
Molecular FormulaC11H17NO4S
Molecular Weight259.32
Purity98%
Density1.3±0.1 g/cm3
Boiling Point464.8±40.0 °C at 760 mmHg
Melting Point76-82 °C(lit.)
Appearancesolid
EINECS265-250-7
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 64838-55-7 |
| Catalog No. | 2A-9000328 |
| Chinese Name | D-(S)-3-乙酰巯基-2-甲基丙酰基-L-脯氨酸 |
| Synonyms | EINECS 265-250-7; MFCD00792449; (S)-3-Acetylthio-2-methylpropionyl-L-proline; 1-[(2S)-3-(Acetylsulfanyl)-2-methylpropanoyl]-L-proline; (2S)-1-(3-Acetylthio-2-methyl-1-oxopropyl)-L-proline |
| Molecular Formula | C11H17NO4S |
| Molecular Weight | 259.32 |
| Purity | 98 |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 464.8±40.0 °C at 760 mmHg |
| Melting Point | 76-82 °C(lit.) |
| Appearance | solid |
| Storage Condition | Store in a sealed container in a cool, dry place. |
| Application | Captopril EP Impurity J is an impurity of Captopril. Captopril is a sulfhydryl-containing, orally active angiotensin-converting enzyme (ACE) inhibitor (IC50=0.025 μM). |
| EINECS | 265-250-7 |
| HTC | 2933990090 |
| SMILES | S(C[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)[O-])C(=O)C |
| InChI | 1S/C11H17NO4S/c1-7(6-17-8(2)13)10(14)12-5-3-4-9(12)11(15)16/h7,9H,3-6H2,1-2H3,(H,15,16)/p-1/t7-,9+/m1/s1 |
| InChI Key | ZNQRGUYIKSRYCI-APPZFPTMSA-M |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| Hazard Symbols | Transport |
| MSDS | msds/328_1_64838_55_7.pdf |
| Bioactivity | Captopril EP Impurity J is an impurity of Captopril. Captopril (SQ-14534), antihypertensive agent, is a thiol-containing competitive, orally active angiotensin-converting enzyme (ACE) inhibitor (IC50=0.025 μM)[1][2][3]. Related Catalog Research Areas >> Others Signaling Pathways >> Others >> Others References [1]. Li, Hp, et al. Synthesis and characterization of captopril derivatives. Res Chem Intermed 39, 621-629 (2013). [2]. Afrin S, et al. Eritadenine from Edible Mushrooms Inhibits Activity of Angiotensin Converting Enzyme in Vitro. J Agric Food Chem. 2016;64(11):2263-2268. [3]. Esmaeili S, et al. Captopril/enalapril inhibit promiscuous esterase activity of carbonic anhydrase at micromolar concentrations: An in vitro study. Chem Biol Interact. 2017;265:24-35. Chemical & Physical Properties Density 1.3±0.1 g/cm3 Boiling Point 464.8±40.0 °C at 760 mmHg Melting Point 76-82 °C(lit.) Molecular Formula C11H17NO4S Molecular Weight 259.322 Flash Point 234.9±27.3 °C Exact Mass 259.087830 PSA 99.98000 LogP 0.40 Vapour Pressure 0.0±2.5 mmHg at 25°C Index of Refraction 1.549 InChIKey ZNQRGUYIKSRYCI-APPZFPTMSA-N SMILES CC(=O)SCC(C)C(=O)N1CCCC1C(=O)O |
| Use of | Captopril EP Impurity J is an impurity of Captopril. Captopril (SQ-14534), antihypertensive agent, is a thiol-containing competitive, orally active angiotensin-converting enzyme (ACE) inhibitor (IC50=0.025 μM)[1][2][3]. Properties Name N-[3-(Acetylthio)-(2S)-methylpropionyl]-L-proline hydrate Synonym More Synonyms Captopril EP Impurity J Biological Activity Description Captopril EP Impurity J is an impurity of Captopril. Captopril (SQ-14534), antihypertensive agent, is a thiol-containing competitive, orally active angiotensin-converting enzyme (ACE) inhibitor (IC50=0.025 μM)[1][2][3]. Related Catalog Research Areas >> Others Signaling Pathways >> Others >> Others References [1]. Li, Hp, et al. Synthesis and characterization of captopril derivatives. Res Chem Intermed 39, 621-629 (2013). [2]. Afrin S, et al. Eritadenine from Edible Mushrooms Inhibits Activity of Angiotensin Converting Enzyme in Vitro. J Agric Food Chem. 2016;64(11):2263-2268. [3]. Esmaeili S, et al. Captopril/enalapril inhibit promiscuous esterase activity of carbonic anhydrase at micromolar concentrations: An in vitro study. Chem Biol Interact. 2017;265:24-35. Chemical & Physical Properties Molecular Formula C11H17NO4S Exact Mass 259.087830 PSA 99.98000 Index of Refraction 1.549 InChIKey ZNQRGUYIKSRYCI-APPZFPTMSA-N |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 United Nations shipping name European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-2-Hydroxy-3-phenylpropionic acid | 20312-36-1 | 2A-9000323 |
| (S)-2-Methoxycyclohexanone | 155320-76-6 | 2A-9000324 |
| (S)-2-Methylpiperazine-2,3-digydroxyszc cinate | 126458-15-9 | 2A-9000325 |
| (S)-2-Nitro-N-(1-phenyl-2-pyrrolidin-1-yl-ethyl)benzenesulfonamide | 2A-100326 | 2A-9000326 |
| (S)-2-Phenylglycinol | 20989-17-7 | 2A-9000327 |
| (S)-3-Amino-1-benzylpyrrolidine dihydrochloride | 131852-54-5 | 2A-9000329 |
| (S)-3-Amino-1-ethylazepan-2-one | 206434-45-9 | 2A-9000330 |
| (S)-3-Amino-1-N-Boc-pyrrolidine | 147081-44-5 | 2A-9000331 |
| (S)-3-Amino-4-phenylbutyric acid hydrochloride | 138165-77-2 | 2A-9000332 |
| (S)-3-Aminopyrrolidine | 128345-57-3 | 2A-9000333 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA